The Future of Early Disease Detection: Biomarker Tests Market Forecast 2026–2034
The biomarker tests market is surging as clinical workflows prioritize early diagnostic accuracy, disease prevention, and individualized treatment regimens. Biomarker tests analyze biological signatures, including gene sequences, protein expression, and tumor DNA, facilitating accurate diagnosis, predicting patient response to targeted therapies, and tracking clinical progression. Market...
0 Comments 0 Shares 33 Views 0 Reviews